PriceTargets.com logo

Crescent Capital BDC - CCAP Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $16.38
  • Forecasted Upside: 9.68%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 1 Strong Buy Ratings
$14.93 As of 12/17/2025 01:30 PM ET
▲ +0.09 (0.61%)

This chart shows the closing price for CCAP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Crescent Capital BDC Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CCAP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CCAP

Analyst Price Target is $16.38
▲ +9.68% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Crescent Capital BDC in the last 3 months. The average price target is $16.38, with a high forecast of $19.00 and a low forecast of $14.00. The average price target represents a 9.68% upside from the last price of $14.93.

This chart shows the closing price for CCAP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 6 investment analysts is to moderate buy stock in Crescent Capital BDC. This rating has held steady since September 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/25/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/23/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/22/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/22/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/20/2025
  • 1 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/18/2025
  • 1 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
11/17/2025
  • 1 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/17/2025

Latest Recommendations

  • 1 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/8/2025Zacks ResearchUpgradeStrong Sell ➝ Hold
11/14/2025OppenheimerLower TargetOutperform ➝ Outperform$20.00 ➝ $19.00
11/14/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$15.00 ➝ $14.00
11/14/2025Keefe, Bruyette & WoodsLower TargetOutperform ➝ Outperform$17.00 ➝ $15.50
10/15/2025Zacks ResearchDowngradeHold ➝ Strong Sell
8/15/2025LADENBURG THALM/SH SHUpgradeStrong-Buy
7/22/2025Keefe, Bruyette & WoodsUpgradeHold ➝ Moderate Buy
5/16/2025Raymond James FinancialLower TargetOutperform ➝ Outperform$20.00 ➝ $17.00
5/16/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$16.00 ➝ $15.00
5/16/2025Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$18.50 ➝ $17.00
4/28/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$18.00 ➝ $16.00
4/8/2025Keefe, Bruyette & WoodsLower TargetOutperform ➝ Outperform$20.00 ➝ $18.50
2/21/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$19.00 ➝ $18.00
1/29/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$18.00 ➝ $19.00
11/25/2024Keefe, Bruyette & WoodsBoost TargetOutperform ➝ Outperform$19.00 ➝ $20.00
9/30/2024LADENBURG THALM/SH SHInitiated CoverageBuy$20.00
8/15/2024Bank of AmericaLower TargetBuy ➝ Buy$20.00 ➝ $19.00
8/14/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$19.00 ➝ $18.00
7/26/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$18.00 ➝ $19.00
5/23/2024Keefe, Bruyette & WoodsBoost TargetOutperform ➝ Outperform$18.50 ➝ $19.00
5/13/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$16.50 ➝ $18.00
5/10/2024Raymond James FinancialBoost TargetOutperform ➝ Outperform$18.00 ➝ $19.00
2/23/2024OppenheimerBoost TargetOutperform ➝ Outperform$18.00 ➝ $19.00
1/29/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$16.00 ➝ $16.50
11/13/2023Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$16.50 ➝ $16.00
4/10/2023Keefe, Bruyette & WoodsInitiated CoverageOutperform$18.00
2/24/2023OppenheimerLower TargetOutperform$19.00 ➝ $18.00
10/5/2022Raymond James FinancialLower TargetOutperform$20.50 ➝ $18.00
8/12/2022OppenheimerUpgradeMarket Perform ➝ Outperform$20.00 ➝ $19.00
8/12/2022Raymond James FinancialLower TargetOutperform$21.00 ➝ $20.50
4/25/2022Wells Fargo & CompanyLower TargetOverweight$19.50 ➝ $18.50
3/7/2022Wells Fargo & CompanyInitiated CoverageOverweight
1/31/2022Bank of AmericaInitiated CoverageBuy$19.50
11/12/2021Raymond James FinancialBoost TargetOutperform$20.00 ➝ $21.50
7/16/2021OppenheimerInitiated CoverageMarket Perform$19.00
(Data available from 12/17/2020 forward)

News Sentiment Rating

1.36 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/20/2025
  • 7 very positive mentions
  • 3 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
6/19/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/19/2025
  • 2 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/18/2025
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/17/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/17/2025
  • 3 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/16/2025
  • 3 very positive mentions
  • 0 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/16/2025

Current Sentiment

  • 3 very positive mentions
  • 0 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

Crescent Capital BDC logo
Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Read More

Today's Range

Now: $14.93
Low: $14.78
High: $15.03

50 Day Range

MA: $14.14
Low: $13.16
High: $15.02

52 Week Range

Now: $14.93
Low: $13.03
High: $20.19

Volume

90,050 shs

Average Volume

192,574 shs

Market Capitalization

$552.26 million

P/E Ratio

15.24

Dividend Yield

11.28%

Beta

0.55

Frequently Asked Questions

What sell-side analysts currently cover shares of Crescent Capital BDC?

The following Wall Street analysts have issued reports on Crescent Capital BDC in the last year: Keefe, Bruyette & Woods, LADENBURG THALM/SH SH, Oppenheimer Holdings, Inc., Raymond James Financial, Inc., Wall Street Zen, Wells Fargo & Company, and Zacks Research.
View the latest analyst ratings for CCAP.

What is the current price target for Crescent Capital BDC?

0 Wall Street analysts have set twelve-month price targets for Crescent Capital BDC in the last year. Their average twelve-month price target is $16.38, suggesting a possible upside of 10.3%. Oppenheimer Holdings, Inc. has the highest price target set, predicting CCAP will reach $19.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $14.00 for Crescent Capital BDC in the next year.
View the latest price targets for CCAP.

What is the current consensus analyst rating for Crescent Capital BDC?

Crescent Capital BDC currently has 2 hold ratings, 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CCAP.

What other companies compete with Crescent Capital BDC?

Other companies that are similar to Crescent Capital BDC include Carlyle Secured Lending, MidCap Financial Investment, Bain Capital Specialty Finance, Goldman Sachs BDC and Blue Owl Capital. Learn More about companies similar to Crescent Capital BDC.

How do I contact Crescent Capital BDC's investor relations team?

Crescent Capital BDC's physical mailing address is 11100 SANTA MONICA BLVD.SUITE 2000, LOS ANGELES CA, 90025. The company's listed phone number is 310-235-5900 and its investor relations email address is [email protected]. The official website for Crescent Capital BDC is www.crescentbdc.com. Learn More about contacing Crescent Capital BDC investor relations.